financetom
Business
financetom
/
Business
/
Nicolet Bankshares Q1 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nicolet Bankshares Q1 Adjusted Earnings, Revenue Rise
Apr 16, 2024 2:18 PM

04:48 PM EDT, 04/16/2024 (MT Newswires) -- Nicolet Bankshares ( NIC ) reported Q1 adjusted earnings late Tuesday of $1.72 per diluted share, up from $1.45 a year earlier.

Analysts polled by Capital IQ expected EPS of $1.65.

Revenue, expressed as the sum of net interest income and total noninterest income, rose to $82.2 million in the three months ended March 31 from $34.9 million a year earlier.

Analysts surveyed by Capital IQ expected $70 million.

Shares of the company rose 1% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Starbucks Stock Is Tumbling Wednesday: What's Going On?
Starbucks Stock Is Tumbling Wednesday: What's Going On?
May 1, 2024
Starbucks Corp ( SBUX ) shares are trading lower Wednesday following worse-than-expected earnings result for the second quarter. Multiple analysts lowered price targets on the stock following the print. What To Know: Starbucks ( SBUX ) reported second-quarter revenue of $8.6 billion, which missed the consensus estimate of $9.129 billion, according to Benzinga Pro. The company’s top-line results were down 2% year-over-year. Starbucks...
Pfizer Lifts Full-Year 2024 Earnings Outlook Following First-Quarter Beat
Pfizer Lifts Full-Year 2024 Earnings Outlook Following First-Quarter Beat
May 1, 2024
08:44 AM EDT, 05/01/2024 (MT Newswires) -- Pfizer ( PFE ) reported better-than-expected first-quarter results on Wednesday as sales from products in its oncology and specialty care segments offset declines in COVID-19 products, prompting the pharmaceutical giant to raise its full-year earnings outlook. The company now anticipates adjusted earnings of $2.15 to $2.35 per share for 2024, up from its...
BRIEF-Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
BRIEF-Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
May 1, 2024
May 1 (Reuters) - Akari Therapeutics PLC ( AKTX ): * AKARI THERAPEUTICS AND PEAK BIO ANNOUNCE PORTFOLIO PRIORITIZATION PLAN FOR COMBINED GO-FORWARD MERGER ENTITY Source text for Eikon: Further company coverage: ...
Sector Update: Consumer
Sector Update: Consumer
May 1, 2024
08:43 AM EDT, 05/01/2024 (MT Newswires) -- Consumer stocks were declining premarket Wednesday, with the Consumer Staples Select Sector SPDR Fund (XLP) 0.4% lower and the Consumer Discretionary Select Sector SPDR Fund (XLY) recently down 0.6%. Starbucks ( SBUX ) declined by more than 13% after the company reported lower fiscal Q2 adjusted earnings and sales that also missed the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved